Effect of oral postmenopausal hormone replacement on progression of atherosclerosis : a randomized, controlled trial.
about
Hormone therapy for preventing cardiovascular disease in post-menopausal womenHormone therapy for preventing cardiovascular disease in post-menopausal womenLong term hormone therapy for perimenopausal and postmenopausal womenLong term hormone therapy for perimenopausal and postmenopausal womenHormone replacement therapy for preventing cardiovascular disease in post-menopausal womenLong term hormone therapy for perimenopausal and postmenopausal womenEstrogen and progestogen use in postmenopausal women: July 2008 position statement of The North American Menopause Society.Pharmacology of estrogens and progestogens: influence of different routes of administrationLong-term hormone therapy for perimenopausal and postmenopausal women.Hormone replacement therapy and secondary cardiovascular prevention: a meta-analysis of randomized trials.The relationship of menopausal status and rapid menopausal transition with carotid intima-media thickness progression in women: a report from the Los Angeles Atherosclerosis Study.The 2012 hormone therapy position statement of: The North American Menopause Society.Postmenopausal oestrogen replacement therapy and atherosclerosis: can current compounds provide cardiovascular protection?Assessing the role of oestrogen in the prevention of cardiovascular disease.Estrogen, vascular estrogen receptor and hormone therapy in postmenopausal vascular disease.Postmenopausal hormone replacement therapy as antiatherosclerotic therapy.Efficacy of female rat models in translational cardiovascular aging researchWhat is the cardioprotective role of hormone replacement therapy?Evidence-based management of dyslipidemias in women.Impact of female hormones on blood pressure: review of potential mechanisms and clinical studies.Vascular effects of estrogenic menopausal hormone therapy.The association between soy nut consumption and decreased menopausal symptoms.Role of the estrogen and progestin in hormonal replacement therapy on apolipoprotein A-I kinetics in postmenopausal womenHormone replacement therapy and cardiovascular disease: lessons from a monkey model of postmenopausal women.Pharmacologic treatment of type 2 diabetic dyslipidemia.Hormone replacement therapy and peripheral vascular disease in women.Hormone replacement therapy, selective estrogen receptor modulators, and tissue-specific compounds: cardiovascular effects and clinical implications.Clinical appraisal of the Women's Health Initiative.Common carotid artery diameter and cardiovascular risk factors in overweight or obese postmenopausal women.Estrogen and hypertension.The timing hypothesis: Do coronary risks of menopausal hormone therapy vary by age or time since menopause onset?Post menopausal hormones and measures of subclinical atherosclerosis: the multi-ethnic study of atherosclerosis.Postmenopausal hormone therapy and cardiovascular disease in perspective.Changes in remnant and high-density lipoproteins associated with hormone therapy and progression of coronary artery disease in postmenopausal women.Progesterone enhances vascular endothelial cell migration via activation of focal adhesion kinase.Overweight and effect of hormone replacement therapy on lipid profiles in postmenopausal women.Hormone therapy and cardiovascular risk markers and disease: focus on progestagens.Complexities of oestrogen in stroke.Attenuation of rate of change in carotid intima-media thickness by lipid-modifying drugs: impact on clinical outcomes.Menopausal hormone therapy: examining cardiovascular and clinical impacts of treatment.
P2860
Q24187326-EB11C298-D6BE-4128-B070-80B090053D4DQ24197712-93E5C09C-00F8-4B4F-9E06-C7442096B8C3Q24201974-4C06EB2D-922F-4A9B-900F-285D399F757BQ24241279-6D70044F-8737-491D-A1D3-48C1D9D51711Q24244146-78AE707A-20F1-40D8-82BD-3FD2BA3AD1D7Q24246577-C9DCB6F7-280E-4972-B1F4-620DDB615E0DQ24658109-E05D9F70-8030-4DA1-9B77-B23223308C2CQ28268346-5A1038D2-4EFB-4A05-8F6F-B8799CD889D8Q30238978-9CD1EC88-8C56-4B10-953E-BD0B2C8417B7Q33222171-CE54AA84-16EA-4BF6-8EA2-7A77A599B5C5Q34113174-12BE85A7-80BC-4475-B98E-9155AD2CBB0CQ34161400-044BB150-B822-4975-A34C-7DD8B4E98FC5Q34232000-CB944790-AE2C-403A-9DD5-B5B006DAFF5AQ34329552-06A5A4E2-8993-4B8F-A859-40E8D5E8733EQ34375771-DBC3FAD6-E8E0-4E1D-A2BB-AADF1D44E643Q34482151-82B18DB9-140B-41B5-8321-1EB845C740C1Q34958259-B73DDCA7-10A5-4E03-A2B0-2D200D001345Q35058238-01A2C75E-5D99-49F1-84C8-8C506E969593Q35197119-A042788F-C4D5-42ED-AD9F-7DED14998A37Q35574191-B3D902EB-DE56-444A-9C92-ADC9DC8AB55BQ35583311-FBA69932-B0BD-4383-AAE0-4F3258EA9CEBQ35590304-5D61F93A-916A-406A-97F4-3A58828B6C6FQ35590308-40CC6E94-64DA-430B-AB11-6EBBB35AC827Q35757554-EA2B1167-FF7A-49B5-9806-494C6B816148Q35976827-8B386CD2-8A19-41D3-AE44-255A9E0EBDF9Q35981132-208BDFF0-9D9D-4CAE-8393-D24347A6A5E6Q36059933-4D636453-843C-46B7-B439-95BC19DE6A5EQ36072505-F2B3423A-B81D-4870-A7D7-0621DB951104Q36203988-8993D97E-13A2-4430-A5DF-4052ACCAEB22Q36590813-FAB78822-67EF-473D-B59C-C4FF0CAF62F8Q36806086-5AE53012-6513-42EE-97C5-59ACC5D9B622Q36945220-814B9672-D106-4B69-9B51-E5B222FB751EQ37234323-E456155E-CFEC-4CA1-BD85-B7F25DC77EF1Q37237180-47F80642-8E67-48B6-8E6F-3FD040A3BE41Q37295760-20A88540-6E2C-44E5-8448-B996AA4B911FQ37477171-163E5E00-05DE-4A14-8AD7-610E96052DCDQ37608577-85BBED01-9A11-4502-9BD6-69EF0EA85B9FQ37650744-92E06502-5E13-43F0-8F8B-D040AB7F5F54Q37886975-DC8D7E7C-6A90-44AD-90D3-1305A6B40BF6Q38106504-A5010C5A-A5FA-4B6B-9D39-283341365CCC
P2860
Effect of oral postmenopausal hormone replacement on progression of atherosclerosis : a randomized, controlled trial.
description
2001 nî lūn-bûn
@nan
2001 թուականի Փետրուարին հրատարակուած գիտական յօդուած
@hyw
2001 թվականի փետրվարին հրատարակված գիտական հոդված
@hy
2001年の論文
@ja
2001年論文
@yue
2001年論文
@zh-hant
2001年論文
@zh-hk
2001年論文
@zh-mo
2001年論文
@zh-tw
2001年论文
@wuu
name
Effect of oral postmenopausal ...... randomized, controlled trial.
@ast
Effect of oral postmenopausal ...... randomized, controlled trial.
@en
type
label
Effect of oral postmenopausal ...... randomized, controlled trial.
@ast
Effect of oral postmenopausal ...... randomized, controlled trial.
@en
prefLabel
Effect of oral postmenopausal ...... randomized, controlled trial.
@ast
Effect of oral postmenopausal ...... randomized, controlled trial.
@en
P2093
P356
P1476
Effect of oral postmenopausal ...... randomized, controlled trial.
@en
P2093
P304
P356
10.1161/01.ATV.21.2.262
P407
P577
2001-02-01T00:00:00Z